Quotient (QTNT) Reports Q4 Revenue of $9 8M, Loss of $26 87M, Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
24.06.2022 - Financial Position Amended Secured Notes: Reduces the company’s cash obligations by approximately $93 million over the next 36 monthsAnnounces Public Equity Offering: Improving liquidity runwayFY 2022 Revenue of $38.5 Million$83.2 million in cash .
Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Quotient Limited Reports Third Quarter Fiscal 2021 Results and Business Update
Nachrichtenquelle: globenewswire | 01.02.2021, 12:00 | 130
Expanded MosaiQ IH microarray EU launch planned for fourth quarter CY2021
Sales of Alba by Quotient reagents exceed guidance
Strong cash position in place to carry us into commercialization JERSEY, Channel Islands, Feb. 01, 2021 (GLOBE NEWSWIRE) Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its third quarter fiscal 2021 results and other notable developments. Notable developments include the CE marking of the Company s MosaiQ semi-quantitative COVID-19 antibody test, which is an enhanced version of the Company s previously approved COVID antibody test.